Enabling Drug Discovery Targeting Ion Channels

Doug Krafte, Ph.D.

Icagen

Innovation

Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics

Doug Krafte, Ph.D.; Aaron Gerlach, Ph.D.; Neil Castle, Ph.D.

Icagen

Strategy

Icagen on the Road to BIO: Early-Stage Planning for End-Stage Success

Kenneth F. Wertman, Ph.D.

Icagen

Drug Discovery

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

Paul R. August; Mark J. Pincus, M.S.

Icagen

Disease in a Dish: Creating Human Tissues In Vitro

Paul R. August

Icagen

Integrated Innovation: Fostering the New Growth in Pharma

Anil C. Nair, Ph.D.; Kenneth F. Wertman, Ph.D.; Paul R. August; Marcel Patek, Ph.D.

Icagen

Transforming the Pharmaceutical Industry Pipeline with In Silico Approaches

Cynthia A. Challener, Ph.D.

Pharma's Almanac